Developer docs
API playgroundTry for free, no card

Search company profiles

Rovia Clinical Research

Full company profile

uuid0006xda

Namestring
Rovia Clinical Research
Legal namestring
Rovia Clinical Research LLC
Company typeenum
Private
Founded yearint
2007
Descriptiontext

Rovia Clinical Research is a U.S.-based multi-specialty clinical research site network founded in 2007 and headquartered in Jacksonville, Florida. The company operates 17 wholly owned research sites across Florida, Mississippi, Georgia, Louisiana, Tennessee, Missouri, and North Carolina, combining free-standing research sites with sites embedded in community physician offices. Through these community physician partnerships, Rovia maintains direct electronic medical record (EMR) access for patient identification and recruitment, which is the core technological enabler of its operating model. The company delivers rapid study start-up, patient enrollment, and high-quality data to enterprise customers including major global pharmaceutical companies, biotechnology companies, and contract research organizations (CROs).

Rovia's service offering is fundamentally a professional services / site-management model rather than a software product. Revenue is generated through contract fees for executing clinical trials on behalf of sponsors, typically structured as per-study or milestone-based arrangements. Centralized teams handle activation, patient recruitment, and oversight, while site-level staff execute protocols and manage participants. The company cites 18+ years of operational experience, 100% reported patient satisfaction, and embedded community physician relationships as its primary competitive differentiators. Recent operating activity in 2025 includes the acquisition of Studymetrix Research and Coastal Research Institute, a new site partnership with Hattiesburg Clinic, and a senior loan from Marathon Asset Management to fund continued expansion.

Go-to-market is enterprise field sales—Rovia contracts directly with global pharma sponsors, biotechs, and CROs seeking fast study activation, enrollment performance, and access to diverse patient populations across multiple therapeutic areas. The customer base is segmented into pharmaceutical sponsors, biotech companies, CROs, and patients (the latter accessed via community physician referrals and a Refer-a-Friend program offering up to $100 gift cards). The company reports HIPAA compliance and applies state-level data protection protocols in its Florida, Tennessee, and Louisiana operations. Pricing is not publicly disclosed, consistent with its B2B contract-services model.

Short descriptiontext

Rovia Clinical Research is a US-based multi-specialty clinical research site network operating 17 wholly owned sites that partner with community physicians to execute clinical trials for global pharmaceutical sponsors, biotechs, and CROs, generating revenue through per-study and milestone-based contracts.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersJacksonville, United States
HQ citystring
Jacksonville
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices14 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical trial services, clinical research sites, patient recruitment services, multi-specialty site network, clinical study execution
Industry3 codes
1Site Network Operators & SMOs
CodeHLAGACAAPrimaryYes
2Patient Recruitment, Site Feasibility & Trial Enablement CROs
CodeHLAGAAAIPrimaryNo
3Site Identification & Feasibility
CodeHLAGACABPrimaryNo
NAICS code2 codes
  • Professional, Scientific, and Technical Services54
  • Medical and Diagnostic Laboratories6215
SIC code2 codes
  • Services-Health Services8000
  • Services-Commercial Physical & Biological Research8731
Product category
Clinical Research Site Network Services
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Clinical Trial Services
TypeProfessional Services
Description

Rovia generates revenue by executing clinical trials on behalf of pharmaceutical sponsors, biotech companies, and CROs. The company provides site-based clinical research services including patient enrollment, study execution, and data delivery. Revenue is earned through contract fees for study execution, typically structured as per-study or milestone-based arrangements.

roviaclinical.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Rovia Clinical Research operates a U.S.-based network of 17 wholly owned multi-specialty clinical research sites that contract directly with pharmaceutical sponsors, biotech companies, and CROs to execute clinical trials. Services include rapid study start-up, centralized patient recruitment, enrollment and retention across diverse patient populations, and standardized study execution with centralized oversight and SOPs. The company combines free-standing sites with sites embedded in community physician offices to enable direct EMR access and efficient patient identification.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 17 sites across multiple U.S. states providing broad geographic reach and patient access
+2 more records
Product overview1 text field

Rovia Clinical Research operates as a clinical trial management service provider with a network of 17 wholly owned research sites across the United States. The company offers centralized patient recruitment, rapid study activation, enrollment target achievement, and consistent high-quality study execution. Services include rapid study start-up through dedicated centralized teams, compassionate patient care with flexible scheduling, and centralized oversight with reliable SOPs. The company partners with major global pharmas, biotechs, and CROs to deliver fast study start-up, patient enrollment, and high-quality data delivery with access to diverse patient populations. No discrete named software products or modules are identified—the offering is fundamentally a service-based model centered on the physical site network and operational expertise.

Product and service4 records
1Clinical Research Site Network Services
CategoryClinical Trial Site Network Services
Description

U.S.-based multi-specialty clinical research site network of 17 wholly owned sites providing rapid study start-up, centralized patient recruitment, enrollment, retention, and high-quality data delivery to pharmaceutical sponsors, biotech companies, and CROs. Services are delivered through a mix of free-standing sites and physician-office-embedded sites with direct EMR access.

2Rapid Study Start-Up Services
CategoryClinical Trial Site Network Services
Description

Dedicated centralized teams that streamline activation and prioritize rapid first patient enrollment across the site network for sponsor trials.

3Enrollment, Retention & Diversity Services
CategoryClinical Trial Patient Recruitment Services
Description

Patient enrollment, retention, and diversity services delivered through 17 sites, patient-centered physicians, and flexible scheduling with reported 100% patient satisfaction.

4Quality & Compliance Study Execution Services
CategoryClinical Trial Quality and Compliance Services
Description

Centralized oversight, reliable SOPs, and timely data practices ensuring consistent, compliant, and high-quality study execution across every site, with patient safety as the top priority.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-10-30
Description

Rovia Clinical Research announced a partnership with Hattiesburg Clinic to launch a new clinical research site at Hattiesburg, Mississippi, in partnership with Dr. Rambod Rouhbakhsh. This expansion strengthens Rovia's presence in Mississippi and enhances capabilities in strategic therapeutic areas.

2Dr. Rambod Rouhbakhsh
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Dr. Rambod Rouhbakhsh serves as the physician partner for the new Hattiesburg Clinic research site, bringing expertise to strengthen Rovia's research capabilities in Mississippi.

prnewswire.com
Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Market position
Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance5 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Rovia Clinical Research

Clinical Research Site Network Servicesroviaclinical.com

Rovia Clinical Research is a US-based multi-specialty clinical research site network operating 17 wholly owned sites that partner with community physicians to execute clinical trials for global pharmaceutical sponsors, biotechs, and CROs, generating revenue through per-study and milestone-based contracts.

What Rovia Clinical Research does

Rovia Clinical Research is a U.S.-based multi-specialty clinical research site network founded in 2007 and headquartered in Jacksonville, Florida. The company operates 17 wholly owned research sites across Florida, Mississippi, Georgia, Louisiana, Tennessee, Missouri, and North Carolina, combining free-standing research sites with sites embedded in community physician offices. Through these community physician partnerships, Rovia maintains direct electronic medical record (EMR) access for patient identification and recruitment, which is the core technological enabler of its operating model. The company delivers rapid study start-up, patient enrollment, and high-quality data to enterprise customers including major global pharmaceutical companies, biotechnology companies, and contract research organizations (CROs).

Rovia's service offering is fundamentally a professional services / site-management model rather than a software product. Revenue is generated through contract fees for executing clinical trials on behalf of sponsors, typically structured as per-study or milestone-based arrangements. Centralized teams handle activation, patient recruitment, and oversight, while site-level staff execute protocols and manage participants. The company cites 18+ years of operational experience, 100% reported patient satisfaction, and embedded community physician relationships as its primary competitive differentiators. Recent operating activity in 2025 includes the acquisition of Studymetrix Research and Coastal Research Institute, a new site partnership with Hattiesburg Clinic, and a senior loan from Marathon Asset Management to fund continued expansion.

Go-to-market is enterprise field sales—Rovia contracts directly with global pharma sponsors, biotechs, and CROs seeking fast study activation, enrollment performance, and access to diverse patient populations across multiple therapeutic areas. The customer base is segmented into pharmaceutical sponsors, biotech companies, CROs, and patients (the latter accessed via community physician referrals and a Refer-a-Friend program offering up to $100 gift cards). The company reports HIPAA compliance and applies state-level data protection protocols in its Florida, Tennessee, and Louisiana operations. Pricing is not publicly disclosed, consistent with its B2B contract-services model.

Rovia Clinical Research firmographics

Firmographics
Name
Rovia Clinical Research
Legal name
Rovia Clinical Research LLC
Website
https://roviaclinical.com
Company type
Private
Founded year
2007
Operating status
Operating
Headcount range
51–100 employees
Short description
Rovia Clinical Research is a US-based multi-specialty clinical research site network operating 17 wholly owned sites that partner with community physicians to execute clinical trials for global pharmaceutical sponsors, biotechs, and CROs, generating revenue through per-study and milestone-based contracts.
Ownership category
akta.pro rank

Rovia Clinical Research industry classification

Industry
Product category
Clinical Research Site Network Services
NAICS
Professional, Scientific, and Technical Services (54), Medical and Diagnostic Laboratories (6215)
SIC
Services-Health Services (8000), Services-Commercial Physical & Biological Research (8731)
akta.pro primary industry
Site Network Operators & SMOs (HLAGACAA)
akta.pro secondary industries
Patient Recruitment, Site Feasibility & Trial Enablement CROs (HLAGAAAI), Site Identification & Feasibility (HLAGACAB)

Keywords

  • Clinical trial services
  • Clinical research sites
  • Patient recruitment services
  • Multi-specialty site network
  • Clinical study execution

Where Rovia Clinical Research is headquartered

Location

Headquarters

HQ city
Jacksonville
HQ country
United States
HQ region
North America

Offices14 records

Markets served

Rovia Clinical Research business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

  1. Clinical Trial Services: Rovia generates revenue by executing clinical trials on behalf of pharmaceutical sponsors, biotech companies, and CROs. The company provides site-based clinical research services including patient enrollment, study execution, and data delivery. Revenue is earned through contract fees for study execution, typically structured as per-study or milestone-based arrangements.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Rovia Clinical Research product offering

Product offering

Core offering

Rovia Clinical Research operates a U.S.-based network of 17 wholly owned multi-specialty clinical research sites that contract directly with pharmaceutical sponsors, biotech companies, and CROs to execute clinical trials. Services include rapid study start-up, centralized patient recruitment, enrollment and retention across diverse patient populations, and standardized study execution with centralized oversight and SOPs. The company combines free-standing sites with sites embedded in community physician offices to enable direct EMR access and efficient patient identification.

Product overview

Rovia Clinical Research operates as a clinical trial management service provider with a network of 17 wholly owned research sites across the United States. The company offers centralized patient recruitment, rapid study activation, enrollment target achievement, and consistent high-quality study execution. Services include rapid study start-up through dedicated centralized teams, compassionate patient care with flexible scheduling, and centralized oversight with reliable SOPs. The company partners with major global pharmas, biotechs, and CROs to deliver fast study start-up, patient enrollment, and high-quality data delivery with access to diverse patient populations. No discrete named software products or modules are identified—the offering is fundamentally a service-based model centered on the physical site network and operational expertise.

Differentiator

Problem solved

Functional benefit

Products and services

  • Clinical Research Site Network Services U.S.-based multi-specialty clinical research site network of 17 wholly owned sites providing rapid study start-up, centralized patient recruitment, enrollment, retention, and high-quality data delivery to pharmaceutical sponsors, biotech companies, and CROs. Services are delivered through a mix of free-standing sites and physician-office-embedded sites with direct EMR access.
  • Rapid Study Start-Up Services Dedicated centralized teams that streamline activation and prioritize rapid first patient enrollment across the site network for sponsor trials.
  • Enrollment, Retention & Diversity Services Patient enrollment, retention, and diversity services delivered through 17 sites, patient-centered physicians, and flexible scheduling with reported 100% patient satisfaction.
  • Quality & Compliance Study Execution Services Centralized oversight, reliable SOPs, and timely data practices ensuring consistent, compliant, and high-quality study execution across every site, with patient safety as the top priority.

Quantifiable outcome

  • 17 sites across multiple U.S. states providing broad geographic reach and patient access
  • +2 more outcomes

Companies that use Rovia Clinical Research

Customer profile

Named customers4 records

Segments4 records

Ideal customer profiles4 records

Rovia Clinical Research technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Rovia Clinical Research partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core.

  • Hattiesburg CliniccoreStrategic or Co-development Partner · 30 October 2025Rovia Clinical Research announced a partnership with Hattiesburg Clinic to launch a new clinical research site at Hattiesburg, Mississippi, in partnership with Dr. Rambod Rouhbakhsh. This expansion strengthens Rovia's presence in Mississippi and enhances capabilities in strategic therapeutic areas.
  • Dr. Rambod RouhbakhshcoreStrategic or Co-development PartnerDr. Rambod Rouhbakhsh serves as the physician partner for the new Hattiesburg Clinic research site, bringing expertise to strengthen Rovia's research capabilities in Mississippi.

Scale indicators3 records

Recent moves7 records

Expansion highlights5 records

Rovia Clinical Research competitors and assessment

Company assessment

Market position

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Rovia Clinical Research social profiles

Digital presence

Rovia Clinical Research compliance and trust

Trust signal

Compliance5 records

Rovia Clinical Research financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Rovia Clinical Research leadership team

Management profile

Number of profiles

Profiles6 records

Rovia Clinical Research funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Rovia Clinical Research M&A and investment

M&A and investment

M&A2 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Rovia Clinical Research

What does Rovia Clinical Research do?

Rovia Clinical Research operates a U.S.-based network of 17 wholly owned multi-specialty clinical research sites that contract directly with pharmaceutical sponsors, biotech companies, and CROs to execute clinical trials. Services include rapid study start-up, centralized patient recruitment, enrollment and retention across diverse patient populations, and standardized study execution with centralized oversight and SOPs. The company combines free-standing sites with sites embedded in community physician offices to enable direct EMR access and efficient patient identification.

Is Rovia Clinical Research a public or private company?

Rovia Clinical Research is a private company. It is classified as unknown and is currently operating.

When was Rovia Clinical Research founded?

Rovia Clinical Research was founded in 2007. It employs 51 to 100 people.

Where is Rovia Clinical Research based?

Rovia Clinical Research is headquartered in Jacksonville, United States, in the North America region.

How does Rovia Clinical Research make money?

One revenue line is on record: clinical Trial Services.

Does Rovia Clinical Research have an API?

No public API is recorded for Rovia Clinical Research.

What industry is Rovia Clinical Research in?

Rovia Clinical Research's product category is Clinical Research Site Network Services. Its primary akta.pro industry code is HLAGACAA, Site Network Operators & SMOs, with a secondary code of HLAGAAAI, Patient Recruitment, Site Feasibility & Trial Enablement CROs. Its NAICS code is 54 and its SIC code is 8000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Business Wire BlogMarathon Asset Management Provides Senior Financing to Rovia Clinical ResearchMarathon Asset Management has closed a term loan facility for Rovia Clinical Research, a clinical research site management organization with 15 sites across seven states in the Midwest and Southeast. The financing will be used to refinance existing debt and support Rovia's acquisition of two key clinical research sites. Rovia is a portfolio company of Gauge Capital and specializes in enrolling patients in clinical trials across metabolic, cardiovascular, metabolic-associated steatohepatitis, and central nervous system therapeutic areas.SubjectwellPredictability starts with better site supportSubjectWell and Rovia Clinical Research highlighted how integrated site support services, including patient companions and unified portals like OneView, improve clinical trial retention and predictability. The companies reported that these interventions reduced time-to-randomization by 38% and increased contact rates by 25.7% in recent studies.PR NewswireRovia Clinical Research Announces Partnership with the Hattiesburg Clinic to Launch New Research Site in Hattiesburg, MississippiRovia Clinical Research has announced a partnership with Hattiesburg Clinic to launch a new dedicated clinical research site in Hattiesburg, Mississippi, with Dr. Rambod Rouhbakhsh serving as principal investigator. Hattiesburg Clinic is the largest privately-owned, multi-specialty health system in Mississippi with over 450 physicians and providers serving patients across 17 counties. The partnership extends Rovia's footprint into Mississippi and enhances its capabilities in key therapeutic areas, including endocrinology, obesity, cardiology, and gastroenterology.Gauge CapitalDallas Middle-Market Private EquityRovia Clinical Research announced the acquisitions of StudyMetrix Research in the St. Louis Metro Area, Missouri, and Coastal Research Institute in Fayetteville, North Carolina. The acquisitions, funded by a growth investment from Gauge Capital and debt and equity financing from Fidelity Direct Lending, expand Rovia's clinical trial capabilities in obesity, hepatology, gastroenterology, pain, and internal medicine. Both acquired sites bring over 30 years of clinical research experience and enhance Rovia's network to 14 locations with 80 investigators across the United States.